Rowlings P A, Przepiorka D, Klein J P, Gale R P, Passweg J R, Henslee-Downey P J, Cahn J Y, Calderwood S, Gratwohl A, Socié G, Abecasis M M, Sobocinski K A, Zhang M J, Horowitz M M
The International Bone Marrow Transplant Registry, Health Policy Institute, Medical College of Wisconsin, Milwaukee 53226, U.S.A.
Br J Haematol. 1997 Jun;97(4):855-64. doi: 10.1046/j.1365-2141.1997.1112925.x.
Acute graft-versus-host disease (GVHD) severity is graded by pattern of organ involvement and clinical performance status using a system introduced by Glucksberg and colleagues 21 years ago. We examined how well Glucksberg grade predicted transplant outcome and constructed a Severity Index not requiring subjective assessment of performance in 2881 adults receiving an HLA-identical sibling T-cell-depleted (n = 752) or non-T-cell-depleted (n = 2129) bone marrow transplant for leukaemia between 1986 and 1992. Relative risks (RR) of relapse, treatment-related mortality (TRM) and treatment failure (TF) (relapse or death) were calculated for patients with (Glucksberg Grade I, II or III/IV acute (GVHD) versus those without acute GVHD and for patients with distinct patterns of organ involvement regardless of Glucksberg grade. Using data for non-T-cell-depleted transplants, a Severity Index was developed grouping patients with patterns of organ involvement associated with similar risks of TRM and TF. Higher Glucksberg grade predicted poorer outcome; however, patients with the same grade but different patterns of skin, liver or gut involvement often had significantly different outcomes. The revised Severity Index groups patients in four categories, A-D. Compared to patients without acute GVHD, RRs (95% confidence interval) of TF were 0.85 (0.69, 1.05) for patients with Index A, 1.21 (1.02, 1.43) with B, 2.19 (1.78, 2.71) with C, and 5.69 (4.57, 7.08) with D. Prognostic utility of the Index was tested in patients receiving T-cell-depleted transplants; similar RRs of TF were observed. An acute GVHD Severity Index is proposed to enhance design and interpretation of clinical trials in the current era of allogeneic blood and bone marrow transplantation.
急性移植物抗宿主病(GVHD)的严重程度是根据器官受累模式和临床表现状态,采用21年前由格卢克伯格及其同事引入的系统进行分级的。我们研究了格卢克伯格分级对移植结果的预测能力,并针对1986年至1992年间接受 HLA 相同同胞供体的 T 细胞去除(n = 752)或非 T 细胞去除(n = 2129)骨髓移植治疗白血病的2881例成年人构建了一个无需主观评估表现的严重程度指数。计算了发生急性 GVHD(格卢克伯格 I 级、II 级或 III/IV 级)的患者与未发生急性 GVHD 的患者以及无论格卢克伯格分级如何、具有不同器官受累模式的患者的复发、治疗相关死亡率(TRM)和治疗失败(TF,复发或死亡)的相对风险(RR)。利用非 T 细胞去除移植的数据,开发了一个严重程度指数,将具有与 TRM 和 TF 风险相似的器官受累模式的患者分组。较高的格卢克伯格分级预示着较差的结果;然而,具有相同分级但皮肤、肝脏或肠道受累模式不同的患者往往有显著不同的结果。修订后的严重程度指数将患者分为 A - D 四类。与未发生急性 GVHD 的患者相比,A 类指数患者的 TF 的 RR(95%置信区间)为 0.85(0.69,1.05),B 类为 1.21(1.02,1.43),C 类为 2.19(1.78,2.71),D 类为 5.69(4.57,7.08)。在接受 T 细胞去除移植的患者中测试了该指数的预后效用;观察到相似的 TF 的 RR。提出了一个急性 GVHD 严重程度指数,以加强在当前异基因血液和骨髓移植时代的临床试验设计和解释。